For Physicians

Clinical training in hematology/medical oncology

During the first year of training, fellows in both the Hematology/Oncology Track and the Classical Hematology Track divide their time among the Dana-Farber, Massachusetts General Hospital (MGH), and Brigham and Women's Hospital (BWH) campuses. The combined institutions have more than 1,400 inpatient beds, and provide inpatient and ambulatory hematology and oncology care to patients from around the world.

Hematology/Oncology Track: During the clinical year, outpatient hematology and oncology experiences are organized around disease-specific programs, and fellows are supervised directly by faculty mentors in each clinical division. Fellows working in inpatient services provide care and consultative services in hematology and medical oncology to a varied population of patients. Trainees also attend a wide variety of teaching conferences at both the Longwood (Dana-Farber and BWH) and MGH campuses. In addition, there are weekly disease-oriented teaching sessions sponsored by the relevant programs.

Classical Hematology Track: The Classical Hematology track is a new addition to the Dana-Farber/Mass General Brigham Fellowship program. Interested applicants can begin submitting applications for the Classical Hematology Track in July 2022. The goal of the Classical Hematology Track is to prepare physicians for both clinical and research careers in classical hematology. During the clinical year, outpatient malignant and non-malignant hematology experiences will be organized around disease-specific programs, and fellows will be supervised directly by faculty mentors in each clinical division. Fellows working in inpatient services will provide care and consultative services in malignant and non-malignant hematology to a varied population of patients. Trainees will also attend a wide variety of teaching conferences at both the Longwood (Dana-Farber and BWH) and MGH campuses. Conferences will include joint conferences with the fellows in the Hematology/Oncology Track and conferences designed specifically for the Classical Hematology fellows.

Training beyond the first year

In the second year and beyond, fellows in both the Hematology/Oncology Track and the Classical Hematology Track begin a period of immersive research, with the aim of assuming independent research programs in respected academic institutions.

A variety of investigative opportunities, ranging from the most fundamental molecular biology to clinical trials and health outcome analyses, are available at Dana-Farber, Brigham and Women's Hospital, and MGH, as well as in laboratories located at the MGH Cancer Center in Charlestown, the Harvard Medical School, Boston Children's Hospital, and the Broad Institute of MIT and Harvard. Additional clinical training is available for those in the Hematology/Oncology Track desiring to board in hematology. Additionally, upper-level fellows maintain a longitudinal continuity clinic in the disease center and campus of their choosing.

Current Fellows

Daniel Ardeljan, MD, PhD

Daniel Ardeljan is originally from New York City. Daniel obtained his BS in Cell & Molecular Biology at Duke University and a combined MD/PhD from The Johns Hopkins University School of Medicine. He completed his residency in the Osler Medical Training Program at the Johns Hopkins Hospital. Prior to medical school, he served as a post-baccalaureate intramural research training associate at the National Institutes of Health studying age-related eye disease. He then attended the Johns Hopkins University Medical Scientist Training Program ... Read Daniel's full profile.

Narsis Attar, MD, PhD

Narsis Attar was born in Iran and grew up in California. Narsis earned her bachelor’s degree in Molecular and Cell Biology from University of California, Berkeley. She obtained her MD/PhD through the Medical Scientist Training Program at the University of California Los Angeles and completed her residency in Internal Medicine at the Massachusetts General Hospital. Prior to medical school, Narsis conducted basic and translational research studying immunotherapy and targeted therapy in metastatic melanoma at UCLA. She completed her PhD studies in Molecular Biology at UCLA ... Read Narsis's full profile.

Mary Boulanger, MD

Mary Boulanger grew up in Lexington, KY. She earned a BS in Human Nutrition and MD at the University of Kentucky. She then completed her internal medicine residency at Johns Hopkins. During her residency, Mary conducted clinical research in thoracic oncology focused on survivorship care and palliative care. ... Read Mary's full profile.

Jamie O. Brett, MD, PhD

Jamie Brett grew up in the Bay Area of Northern CA. Jamie went to Stanford for her undergraduate degree, where she worked on neural stem cell aging. She remained at Stanford for her MD and PhD degrees, investigating skeletal muscle stem cell quiescence, aging, and rejuvenation by exercise. Jamie then came to MGH for her Internal Medicine residency, where she researched resistance mechanisms and later-line therapies for hormone receptor-positive breast cancer. ... Read Jamie's full profile.

Allison E.B. Chang, MD, PhD

Allison Chang is originally from Farmington, CT. She attended Dartmouth College, where she studied neuroscience and chemistry. Allison then pursued a PhD in neurobiology at Harvard, where she studied the cellular and synaptic mechanisms by which neurons derive meaning from auditory and mechanosensory stimuli. After completing her PhD, Allison earned an MD at Harvard Medical School. Her residency training was at Brigham and Women’s Hospital ... Read Allison's full profile.

Matthew J. Emmett, MD, PhD

Matthew Emmett is originally from Philadelphia, PA. He obtained a BA in Biology and MS in Molecular and Cellular Biology at Johns Hopkins University, and an MD and PhD at the University of Pennsylvania. Matthew completed his doctoral dissertation studying the epigenomic and transcriptional regulation of metabolism. Following medical school, he completed his residency in Internal Medicine at the Massachusetts General Hospital, where he conducted clinical research in GI oncology ... Read Matthew's full profile.

Emma C. Fink, MD, PhD

Emma Fink is originally from Ontario, NY. She attended Amherst College, where she double majored in Biology and Chemistry. She then came to the Harvard-MIT MD/PhD program, where she completed her MD in the HST program and PhD in the BBS program. Emma continued her clinical training at Brigham and Women’s Hospital, where she completed her residency in Internal Medicine ... Read Emma's full profile.

Benson M. George, MD, PhD

Benson George is originally from East Meadow, NY. He obtained a BS in Biology at MIT, obtained an MD and PhD from Stanford University, and completed his residency in Internal Medicine at Brigham and Women’s Hospital. His thesis work investigated immunotherapeutic approaches for conditioning prior to hematopoietic stem cell transplant ... Read Benson's full profile.

Eran Hodis, MD, PhD

Eran Hodis is originally from Framingham, MA. He earned a BA in mathematics and biochemistry/molecular biology at Boston University, an MSc in bioinformatics from the Weizmann Institute of Science in Rehovot, Israel, a PhD in biophysics from Harvard University, and an MD from the HST program at Harvard Medical School and MIT. Eran completed residency in Internal Medicine at Brigham and Women’s Hospital ... Read Eran's full profile.

Sara J. Khosrowjerdi, MD

Sara Khosrowjerdi is originally from Wilbraham, MA (home of Friendly’s Ice Cream). She graduated summa cum laude from Tufts University, obtaining a BS in Biochemistry and BA in English. She earned her MD from Tufts University School of Medicine and completed her residency in Internal Medicine at Massachusetts General Hospital. Prior to medical school, she conducted research at Tufts University, synthesizing cyclic peptides to probe protein-protein interactions in the EGFR signaling pathway ... Read Sara's full profile.

Lauren Merz, MSc, MD

Lauren Merz is originally from Michigan. She obtained a BA in Kinesiology and Spanish from Calvin College, where she played varsity soccer and studied abroad in Spain, Mexico, and Honduras. She then obtained an MD from the University of Michigan Medical School and an MSc in Clinical Research from the University of Michigan School of Public Health before completing an Internal Medicine residency at Brigham and Women’s Hospital. While in medical school, she led the University of Michigan Student-Run Free Clinic ... Read Lauren's full profile.

Ian A. Roundtree, MD, PhD

Ian Roundtree is originally from Dunstable, MA. He obtained his undergraduate degree in Chemistry at Boston College, where he conducted research in synthetic organic chemistry. He then moved to Chicago, where he joined the Medical Scientist Training Program at the University of Chicago (PhD 2017, MD 2020). His doctoral research involved elucidating the role of reversible RNA modification in regulating gene expression. He completed his residency in Internal Medicine at the Massachusetts General Hospital as part of the Stanbury Physician Scientist Program ... Read Ian's full profile.

Elliot C. Woods, MD, PhD

Elliot Woods was born in Minneapolis, MN, but spent the latter half of his formative years in the Southeastern U.S. He received his bachelor’s degree in Chemical Engineering with a focus in biochemistry from the University of Pennsylvania. Elliot began his MD training at Emory University in Atlanta, but ended up at UC/Berkeley for a PhD in Bioengineering, working to characterize the role of glycans in oncogenesis. He completed his residency in Internal Medicine at Massachusetts General Hospital ... Read Elliot's full profile.

Past Fellows

Second Year Fellows 2021

Jordan M. Chinai, MD, PhD, Fellow DFCI/MGB
Charles S. Dai, MD, Fellow DFCI/MGB
Elijah P.B. Darnell, MD, Fellow DFCI/MGB
Haley Ellis, MD, Fellow DFCI/MGB
Dan Y. Gui, MD, PhD, Fellow DFCI/MGB
Alexander C. Jordan, MD, Fellow DFCI/MGB
Mwanasha H. Merrill, MD, Fellow DFCI/MGB
Abirami Natarajan, MD, Fellow DFCI/MGB
Rachel H. Occhiogrosso, MD, Fellow DFCI/MGB
Leon Pappas, MSc, MD, PhD, Fellow DFCI/MGB
Nolan Priedigkeit, MD, PhD, Fellow DFCI/MGB
John C. Schell, MD, PhD, Fellow DFCI/MGB
Vinayak Venkataraman, MD, Fellow DFCI/MGB
Jeremiah Wala, MS, MD, PhD, Fellow DFCI/MGB

Third Year Fellows 2020

Justin S. Becker, MD, PhD, Fellow DFCI/MGB
Elliott J. Brea, MD, PhD, Fellow DFCI/MGB
Elizabeth J. Carstens, MD, Fellow DFCI/MGB
Jooho Chung, MD, PhD, Fellow DFCI/MGB
Alissa J. Cooper, MD, Fellow DFCI/MGB
Brandon M. Huffman, MD, Fellow DFCI/MGB
Nathalie R. Javidi-Sharifi MD, PhD, Fellow DFCI/MGB
Janice S. Kim, MD, Fellow DFCI/MGB
Marla D. Lipsyc-Sharf, MD, Fellow DFCI/MGB
Asaf Maoz, MD, Fellow DFCI/MGB
Richard A. Newcomb, MD, Fellow DFCI/MGB
Erica M. Pimenta, MD, PhD, Fellow DFCI/MGB
Thomas J. Roberts, MD, MBA, Fellow DFCI/MGB
Christine E. Ryan, MD, Fellow DFCI/MGB
Maclean S. Sellers, MD, PhD, Fellow DFCI/MGB
Rebecca L. Zon, MD, Fellow DFCI/MGB

2019

Evan C. Chen, MD, Medical Oncologist at Dana Farber Cancer Institute
William J. Gibson, MD, PhD, Fellow DFCI/MGB
Julie E. Haydu, MD, PhD, Medical Oncologist at Massachusetts General Hospital
Daniel E. Lage, MD, MBA, MSc, Medical Oncologist at Massachusetts General Hospital
Jaclyn LoPiccolo, MD, PhD, Fellow DFCI/MGB
Alexandra K. Maurer, MD, PhD, Medical Oncologist at Dana Farber Cancer Institute
Catherine B. Meador, M, PhD, Medical Oncologist at Massachusetts General Hospital
Arielle J. Medford, MD, Fellow DFCI/MGB
Arnav Mehta, MD, PhD, Medical Oncologist at Massachusetts General Hospital
Vivek Naranbhai, MBCHB, PhD, DPhil, Fellow DFCI/MGB
Philipp J. Rauch, MD, Medical Oncologist at Dana Farber Cancer Institute
Aswin Sekar, MD, PhD, Fellow DFCI/MGB
Eleni Stavrou, MD, Memorial Sloan Kettering Cancer Center
Matthew R. Strickland, MD, Medical Oncologist at Massachusetts General Hospital

2018

Steven M. Blum, MD, Medical Oncologist at Dana-Farber Cancer Institute
Cynthia K. Hahn, MD, PhD, Fellow DF/MGB
Chi-Joan How, MD, Medical Oncologist at Dana-Farber Cancer Institute
P. Connor Johnson, MD, Instructor in Medicine at Massachusetts General Hospital
Jonathan M.L. Ostrem, MD, PhD, Assistant Professor UCSF
Jeffrey W. Patterson-Fortin, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
Rishi Puram, MD, PhD, Fellow DF/MGB
Praful K. Ravi, MBBCh, Medical Oncologist at Dana-Farber Cancer Institute
Jaime L. Schneider, MD, PhD, Medical Oncologist at Massachusetts General Hospital
Frederick D. Tsai, MD, PhD, Fellow DF/MGB
Vivek Upadhyay, MD, Fellow DF/MGB
Lachelle D. Weeks, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
Kipp A. Weiskopf, MD, PhD, Fellow DF/MGB
Jordan C. Wengrod, MD, PhD, Fellow DF/MGB

2017

Daniel L. Abravanel, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
Sylvan C. Baca, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
Jacob E. Berchuck, MD, Medical Oncologist at Dana-Farber Cancer Institute
Christopher T. Chen, MD, Medical Oncologist at Dana-Farber Cancer Institute
Bradley D. Hunter, MD, MPH, Hematology/Oncology Intermountain Medical Group
Geon Kim, MD, Hematology Attending Massachusetts General Hospital
Erik K. Knelson, MD, PhD, Clinical Director, Early State Oncology, Merck
Elizabeth K. Lee, MD, Medical Oncologist at Dana-Farber Cancer Institute
Mark B. Leick, MD, Medical Oncologist at Massachusetts General Hospital
Christopher S. Nabel, MD, PhD, Medical Oncologist at Massachusetts General Hospital
Alexander A. Parent, MD, PhD, Medical Director, Oncology TAU, at Takeda Pharmaceuticals
Christopher R. Reilly, MD, Medical Oncologist at Dana-Farber Cancer Institute
James A. Torchia, MD, PhD, Fellow DF/MGB
Mounica Vallurupalli, MD, Fellow DF/MGB

Application procedure

All applications for this program are processed through the Electronic Residency Application Service (ERAS). Please note that both tracks are listed under Brigham and Women's Hospital, not Dana-Farber Cancer Institute. Applicants can apply to either one or both tracks.

The deadline for applications is August 31.

Contact us

Kim Bremner
Fellowship Coordinator
Phone: 617-632-3474
Fax: 617-632-2260
Email: kim_bremner@dfci.harvard.edu